Aditxt Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aditxt Inc's ROI in the first quarter of 2026?
Aditxt Inc recorded a cumulative net loss of $-53 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -1182.59%.

Within the Healthcare sector 863 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from to 4737.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Investment Change TTM	-57.22 %	20.22 %	-12.04 %	39.24 %	55.63 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	1	7	-6	17	21
Return On Investment (TTM)	-1182.59 %	-449.01 %	-	-201.06 %	-249.09 %
ADTX's Overall Ranking	# 4737	#	#	#	#
Seq. Investment Change TTM	-52.95 %	-4.27 %	-22.65 %	22.8 %	32.22 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-53	-43	-43	-26	-26

ADTX Company Profile >> Back to ADTX Roi Comparisons >> See Annual ADTX Return On Investment

Return On Investment ADTX's Ranking
Within:	No.
Industry	# 416
Sector	# 864
Overall	# 4737

Return On Investment Statistics
High	Average	Low
-134.35 %	-512.82 %	-3527.75 %
(Mar 31 2021)		(Sep 30 2023)

News about Aditxt Inc Return on Investment ROI

Aditxt and Appili Therapeutics Strengthen Collaboration Through Third Agreement Amendment

August 21, 2024

In a strategic move aimed at bolstering their partnership, Aditxt, Inc. a California-based company focused on health innovations, has announced a third amendment to its arrangement agreement with Appili Therapeutics, a biopharmaceutical firm based in Canada. This collaboration is centered on the mutual goal of accelerating the development of innovative treatments and vaccines for challenging infectious diseases.Aditxt operates on the leading edge of health technology, employing its innovative platform to discover, develop, and deploy nearly applicable health innovations. The company’s focus aims to enhance patient outcomes and address unmet medical needs through cutting-edge technological advancements.

Financial Statements
Aditxt Inc's I. Quarter Investments	$ 1 Millions	ADTX's Balance sheet
Aditxt Inc's I. Quarter Income	$ -16 Millions	Quarterly ADTX's Income Statement
ADTX's Income by Division		See ADTX's Income by Division

ADTX Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	4	8	22	7	13
Y / Y Investment Growth	-48.5 %	-61.99 %	208.5 %	-45.69 %	-0.02 %
Net Income in Millions	-43	-35	-32	-28	-46
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-999.07 %	-421.12 %	-148.05 %	-388.84 %	-355.15 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ADTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ADTX's Competitors
Subscribers only: Roi for Aditxt Inc's Suppliers
Subscribers only: Return On Investment for ADTX's Customers

Other Ratios
ADTX's Roa	ADTX's Inventory Turnover Ratio	ADTX's Growth Rates	ADTX's Dividend Statistics
	ADTX's Profitability Ratios	ADTX's Asset Turnover Ratio	ADTX's Dividend Growth
ADTX's Roe	ADTX's Valuation Ratios	ADTX's Financial Strength Ratios	ADTX's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:40:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.